A systematic review of the neurocognitive effects of magnetic seizure therapy

Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
International Review of Psychiatry (Impact Factor: 1.8). 10/2011; 23(5):413-23. DOI: 10.3109/09540261.2011.623687
Source: PubMed


Magnetic seizure therapy (MST) is a novel neurotherapeutic intervention in development for the treatment of major affective disorders. Like other neurotherapeutic strategies such as electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS), a primary interest will be to monitor the associated neurocognitive effects. Thus, the purpose of this systematic review was to synthesize the available data on the neurocognitive effects of MST. The authors performed two independent literature searches with the following terms terms: MST, magnetic, magnetic seizure therapy, depression, neurocognition, cognitive, preclinical. We included in this review a total of eleven articles that mentioned MST and neurocognition in the abstract. The articles were divided into three methodological domains that included virtual computer simulations, preclinical studies, and clinical investigations. Collectively, the available evidence suggests MST has little to no adverse cognitive effects. Specifically, virtual computer simulations found the magnetic field was localized to grey matter, and preclinical studies found no neurocortical or neurocognitive sequelae. Clinical investigations found MST to be associated with rapid reorientation and intact anterograde and retrograde memory. Future investigations using translational methods are warranted to confirm these findings and to further determine the effects of MST on neurocognitive functions.

Download full-text


Available from: Shawn M Mcclintock
    • "Les sujets dé primé s sembleraient faire des erreurs d'omission. Ces erreurs pourraient e ˆtre lié es aux troubles cognitifs pré sents dans la dé pression comme les troubles de la mé moire ou les troubles de la concentration et de l'attention communé ment dé crits dans la litté rature [15]. Ainsi, les troubles de la mé moire de la source rencontré s chez les sujets dé primé s constitueraient d'avantage un « marqueur e ´ tat » en lien avec l'e ´ tat clinique du sujet. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives Source monitoring is characterized by the ability to recognize the origin of the information. Memory deficits of the source would be an important dimension in the understanding of the hallucinations in schizophrenia. The objective of the study is to compare the performance of the source memory of two resistant populations compared to healthy volunteers. Materials and methods Included subjects were 20 schizophrenic patients with refractory hallucinations, 10 refractory depression and 20 healthy subjects were evaluated. All clinical subjects met criteria for resistant disease. Source memory deficits were measured using a computerized source memory task, consisting of two subtests “hear” and “say”. This task assesses the ability to recognize the source of information that can come from either the subject itself or from an external source. Results Performances of the three groups were compared on the number of correct recognitions for each test and the number of errors, which are the following ones: inversions, false recognitions and omissions. The data appear to reflect cognitive deficits present in each psychiatric population compared with healthy volunteers. These deficits seem to be of different types depending on the population. Refractory hallucinating schizophrenic subjects attribute significantly more auto-generated information to an external source than subjects with refractory depression. Moreover, the errors produced by depressed subjects occur more in information processing capacity as encoding and memory storage deficits. Conclusions Source memory deficits are present in both pathologies. They seem to play a different role depending on disorders presented and are suggested as a cognitive marker to consider.
    No preview · Article · Sep 2014 · Annales Médico-psychologiques revue psychiatrique
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Little is known about the neurobiological foundations of psychotherapy for Posttraumatic Stress Disorder (PTSD). Prior studies have shown that PTSD is associated with altered processing of threatening and aversive stimuli. It remains unclear whether this functional abnormality can be changed by psychotherapy. This is the first randomized controlled treatment trial that examines whether narrative exposure therapy (NET) causes changes in affective stimulus processing in patients with chronic PTSD. 34 refugees with PTSD were randomly assigned to a NET group or to a waitlist control (WLC) group. At pre-test and at four-months follow-up, the diagnostics included the assessment of clinical variables and measurements of neuromagnetic oscillatory brain activity (steady-state visual evoked fields, ssVEF) resulting from exposure to aversive pictures compared to neutral pictures. PTSD as well as depressive symptom severity scores declined in the NET group, whereas symptoms persisted in the WLC group. Only in the NET group, parietal and occipital activity towards threatening pictures increased significantly after therapy. Our results indicate that NET causes an increase of activity associated with cortical top-down regulation of attention towards aversive pictures. The increase of attention allocation to potential threat cues might allow treated patients to re-appraise the actual danger of the current situation and, thereby, reducing PTSD symptoms. REGISTRATION OF THE CLINICAL TRIAL: Number: NCT00563888Name: "Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims" ULR:
    Full-text · Article · Dec 2011 · BMC Neuroscience
  • Source

    Preview · Article · Apr 2012 · Depression and Anxiety
Show more